Shopping Cart

No products in the cart.

CAN/CSA-C22.2 NO. 60601-2-23:12 (R2021):2012 Edition

$47.45

Medical electrical equipment – Part 2-23: Particular requirements for the basic safety and essential performance of transcutaneous partial pressure monitoring equipment

Published By Publication Date Number of Pages
CSA 2012 120
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

Preface

This is the third edition of CAN/CSA-C22.2 No. 60601-2-23, Medical electrical equipment – Part 2-23: Particular requirements for the basic safety and essential performance of transcutaneous partial pressure monitoring equipment, which is an adoption without modification of the identically titled IEC (International Electrotechnical Commission) Standard 60601-2-23 (third edition, 2011-02). It supersedes the previous edition published in 2002 as CAN/CSA-C22.2 No. 60601-2-23 (adopted IEC 60601-2-23:1999). It is one in a series of Standards issued by CSA under Part II of the Canadian Electrical Code.

This Standard is intended to be used in conjunction with CAN/CSA-C22.2 No. 60601-1:08, Medical electrical equipment – Part 1: General requirements for basic safety and essential performance (adopted IEC Standard 60601-1:2005, with Canadian deviations).

This Standard is considered suitable for use for conformity assessment within the stated scope of the Standard.

Scope

Replacement:

This International Standard applies to the BASIC SAFETY and ESSENTIAL PERFORMANCE of TRANSCUTANEOUS PARTIAL PRESSURE MONITORING EQUIPMENT as defined in 201.3.63 and hereinafter referred to as ME EQUIPMENT, whether this ME EQUIPMENT is stand alone or part of a system.

This Standard applies to transcutaneous monitors used with adults, children and neonates, and it includes the use of these devices in foetal monitoring during birth.

This Standard does not apply to haemoglobin saturation oximeters or to devices applied to surfaces of the body other than the skin (for example conjunctiva, mucosa).

If a clause or subclause is specifically intended to be applicable to ME EQUIPMENT only, or to ME SYSTEMS only, the title and content of that clause or subclause will say so. If that is not the case, the clause or subclause applies both to ME EQUIPMENT and to ME SYSTEMS, as relevant.

HAZARDS inherent in the intended physiological function of ME EQUIPMENT or ME SYSTEMS within the scope of this standard are not covered by specific requirements in this standard except in 7.2.13 and 8.4.1 of the general standard.

NOTE See also 4.2 of the General Standard.

CAN/CSA-C22.2 NO. 60601-2-23:12 (R2021)
$47.45